These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24116865)

  • 1. Comparison of acute effect of systemic versus intravitreal infliximab treatment in an experimental model of endotoxin-induced uveitis.
    Yuksel E; Hasanreisoglu B; Yuksel N; Yilmaz G; Ercin U; Bilgihan A
    J Ocul Pharmacol Ther; 2014 Feb; 30(1):74-80. PubMed ID: 24116865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of systemic and intravitreal infliximab treatments in an endotoxin-induced uveitis model.
    Donmez O; Yaman A; Ozturk T; Aktas S; Altun ZS; Yılmaz O
    Cutan Ocul Toxicol; 2019 Dec; 38(4):360-369. PubMed ID: 31213109
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravitreal infliximab in experimental endotoxin-induced uveitis.
    Hosseini H; Safaei A; Khalili MR; Nowroozizadeh B; Eghtedari M; Farvardin M; Nowroozizadeh S; Tolide-Ie HR
    Eur J Ophthalmol; 2009; 19(5):818-23. PubMed ID: 19787603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose infliximab prophylaxis in endotoxin-induced uveitis.
    Diaz-Llopis M; García-Delpech S; Salom D; Udaondo P; Bosch-Morell F; Quijada A; Romero FJ; Amselem L
    J Ocul Pharmacol Ther; 2007 Aug; 23(4):343-50. PubMed ID: 17803432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cannabinoid ligand, anandamide, exacerbates endotoxin-induced uveitis in rabbits.
    Altinsoy A; Dileköz E; Kul O; Ilhan SÖ; Tunccan OG; Seven I; Bagriacik EU; Sarioglu Y; Or M; Ercan ZS
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):545-52. PubMed ID: 21848425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of endothelin receptor antagonists in the endotoxin-induced uveitis rabbit model
    Karaca EE; Uzun F; Dileköz E; Öztürk Fincan GS; Ercan S; Kul O; Bağrıaçık EÜ; Or M
    Cutan Ocul Toxicol; 2018 Jun; 37(2):133-138. PubMed ID: 28707522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF inhibition for ophthalmic indications: current status and outlook.
    Rifkin LM; Birnbaum AD; Goldstein DA
    BioDrugs; 2013 Aug; 27(4):347-57. PubMed ID: 23568177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of infliximab, cyclosporine A and recombinant IL-10 on vitreous cytokine levels in experimental autoimmune uveitis.
    Demir T; Gödekmerdan A; Balbaba M; Türkçüoglu P; Ilhan F; Demir N
    Indian J Ophthalmol; 2006 Dec; 54(4):241-5. PubMed ID: 17090875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic administration of an anti-tumor necrosis factor-alpha monoclonal antibody protects against endotoxin-induced uveitis in rats.
    Ge Q; Wang S; Zheng Y
    Indian J Ophthalmol; 2016 Dec; 64(12):873-877. PubMed ID: 28112125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etanercept treatment in the endotoxin-induced uveitis of rats.
    Avunduk MC; Avunduk AM; Oztekin E; Baltaci AK; Ozyazgan Y; Mogolkoc R
    Exp Eye Res; 2004 Sep; 79(3):357-65. PubMed ID: 15336498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal infliximab for sight-threatening relapsing uveitis in Behçet disease: a pilot study in 15 patients.
    Markomichelakis N; Delicha E; Masselos S; Sfikakis PP
    Am J Ophthalmol; 2012 Sep; 154(3):534-541.e1. PubMed ID: 22789563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of Ginkgo biloba extract on lipopolysaccharide-induced inflammation in vitro and in vivo.
    Ilieva I; Ohgami K; Shiratori K; Koyama Y; Yoshida K; Kase S; Kitamei H; Takemoto Y; Yazawa K; Ohno S
    Exp Eye Res; 2004 Aug; 79(2):181-7. PubMed ID: 15325565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of artesunate on endotoxin-induced uveitis in rats.
    Wang XQ; Liu HL; Wang GB; Wu PF; Yan T; Xie J; Tang Y; Sun LK; Li C
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):916-9. PubMed ID: 20881305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of intravitreal infliximab for treatment of sight-threatening chronic noninfectious uveitis.
    Farvardin M; Afarid M; Shahrzad S
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):628-31. PubMed ID: 22794354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of morphine on the expression of cytokines and inflammatory mediators in a rabbit model of endotoxin-induced experimental uveitis.
    Ortencio KP; Renzo R; Sobrinho B AA; Kobashigawa KK; Crivelaro RM; Silva GA; Aldrovani M; Ribeiro AP; Mineo TW; Laus JL
    Arq Bras Oftalmol; 2015; 78(6):371-5. PubMed ID: 26677041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal administration of the anti-TNF monoclonal antibody infliximab in the rabbit.
    Theodossiadis PG; Liarakos VS; Sfikakis PP; Charonis A; Agrogiannis G; Kavantzas N; Vergados IA
    Graefes Arch Clin Exp Ophthalmol; 2009 Feb; 247(2):273-81. PubMed ID: 18982345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraocular penetration of periocular ketorolac and efficacy in experimental uveitis.
    Rabiah PK; Fiscella RG; Tessler HH
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):613-8. PubMed ID: 8595961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of blue honeysuckle (Lonicera caerulea L.) extract on lipopolysaccharide-induced inflammation in vitro and in vivo.
    Jin XH; Ohgami K; Shiratori K; Suzuki Y; Koyama Y; Yoshida K; Ilieva I; Tanaka T; Onoe K; Ohno S
    Exp Eye Res; 2006 May; 82(5):860-7. PubMed ID: 16309673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study on ocular safety of intravitreal infliximab in a rabbit model.
    Giansanti F; Ramazzotti M; Vannozzi L; Rapizzi E; Fiore T; Iaccheri B; Degl' Innocenti D; Moncini D; Menchini U
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1151-6. PubMed ID: 18326743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Neopterin Levels in an Endotoxin-Induced Experimental Uveitis Model.
    Serif N; Gurelik G; Hasanreisoğlu M; Yaman H; Akyurek N
    Semin Ophthalmol; 2016; 31(3):256-60. PubMed ID: 25310242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.